Nexus BioQuest

Overview

Nexus BioQuest is a contract research organization specializing in immunology drug discovery and translational research. Founded with a clear vision to become a go-to immunology partner, the company provides tailored CRO services addressing complex immune research questions.

Core Services

Drug Discovery: Preclinical drug discovery and non-regulatory clinical biomarker services supporting immune-therapeutic development. The company uses relevant cell lines, primary human cells, and patient material in assays to evaluate target engagement, lead candidate identification, and optimization. Built into the workflow are predictive immunotoxicity and biomarker assays resulting in comprehensive drug candidate data packages.

Bespoke Assay Design: Custom assay development and optimization for drug discovery programs. Recognizing that novel therapeutics rarely fit a one-size-fits-all solution, Nexus BioQuest provides immunological expertise, study design, and execution to address complex immunological questions.

Therapeutic Areas

• Immune-Oncology
• Autoimmunity
• Inflammation and Hypersensitivity
• Neuro-Inflammation

Scientific Approach

The company's experienced immunologists work as true collaborators, designing and executing customized experiments that address specific research objectives while maintaining the highest-quality standards. Whether approaches involve modulating immune responses for therapeutic benefit or targeting immune pathways to treat disease, the team works alongside clients to achieve shared goals.

Differentiation

Nexus BioQuest emphasizes scientific expertise, agility in service delivery, and timely communication. The company takes pride in its ability to communicate intricate scientific concepts, execute detailed project quotes, and deliver comprehensive data packages within agreed timelines.